The Patent Finder

Rational Drug Design with Computational Free Energy Difference Calculation Using a Modified Bond Stretch Potential

Schrödinger, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 14/138,186, filed Dec 23, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,417,821Methods and Systems For Calculating Free Energy Differences Using A Modified Bond Stretch Potential
In force
 · High confidence
Schrödinger, LLCIn force
High confidence
US 11,562,808Rational Drug Design with Computational Free Energy Difference Calculation Using a Modified Bond Stretch Potential
In force
 · High confidence
Schrödinger, LLCIn force
High confidence
Application 19/328,436Methods and Systems For Calculating Free Energy Differences Using A Modified Bond Stretch Potential
Pending
Not granted
Schrödinger, LLCPendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Schrödinger, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited